In This Article:
In the past year, the United Kingdom's market has shown modest growth, rising 7.4%, with a stable performance in the recent week and expectations of earnings growing by 13% annually over the next few years. In this context, undervalued small-cap stocks with insider buying activity can present particularly interesting opportunities for investors looking to potentially benefit from overlooked value in a gradually strengthening market.
Top 10 Undervalued Small Caps With Insider Buying In The United Kingdom
Name | PE | PS | Discount to Fair Value | Value Rating |
---|---|---|---|---|
Mitie Group | 11.5x | 0.3x | 37.93% | ★★★★★★ |
Stelrad Group | 9.3x | 0.5x | 41.65% | ★★★★★★ |
Norcros | 7.8x | 0.5x | 41.37% | ★★★★★☆ |
THG | NA | 0.4x | 33.43% | ★★★★★☆ |
Bytes Technology Group | 28.4x | 6.4x | 13.29% | ★★★★☆☆ |
Ultimate Products | 10.4x | 0.8x | 11.50% | ★★★★☆☆ |
Savills | 36.2x | 0.7x | 25.82% | ★★★☆☆☆ |
Robert Walters | 20.6x | 0.3x | 35.56% | ★★★☆☆☆ |
Henry Boot | 10.5x | 0.8x | -107.18% | ★★★☆☆☆ |
Hochschild Mining | NA | 1.6x | 38.88% | ★★★☆☆☆ |
Here we highlight a subset of our preferred stocks from the screener.
Assura
Simply Wall St Value Rating: ★★★★☆☆
Overview: Assura is a UK-based healthcare real estate investment trust (REIT) specializing in primary care facilities, with a market capitalization of approximately £1.47 billion.
Operations: The entity generates revenue primarily through its core operations, with a recent reported figure of £157.8 million. It has maintained a high gross profit margin consistently above 90%, evidencing strong cost management relative to its revenue generation.
PE: -41.5x
Assura's strategic moves and insider confidence signal potential for growth despite a recent net loss. With a significant reduction in losses from GBP 119.2 million to GBP 28.8 million year-on-year and a forecasted earnings increase of 40.26% annually, the company is poised for recovery. Recently, insiders have shown their belief in the firm’s trajectory through share purchases, underscoring their commitment to its success. Additionally, a new GBP 250 million joint venture aimed at expanding NHS infrastructure underlines Assura's proactive approach in a vital sector, promising further stability and growth opportunities.
-
Click here to discover the nuances of Assura with our detailed analytical valuation report.
-
Evaluate Assura's historical performance by accessing our past performance report.
Aston Martin Lagonda Global Holdings
Simply Wall St Value Rating: ★★★★☆☆
Overview: Aston Martin Lagonda Global Holdings is a luxury automotive manufacturer known for its high-performance sports cars, with a market capitalization of approximately £1.07 billion.